X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5969) 5969
Publication (365) 365
Book Review (141) 141
Newsletter (135) 135
Book Chapter (13) 13
Newspaper Article (11) 11
Magazine Article (8) 8
Conference Proceeding (6) 6
Data Set (2) 2
Dissertation (2) 2
Web Resource (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4977) 4977
risperidone (3857) 3857
psychiatry (3576) 3576
antipsychotic agents - adverse effects (3535) 3535
male (3225) 3225
antipsychotic agents - therapeutic use (2969) 2969
female (2959) 2959
schizophrenia (2432) 2432
adult (2321) 2321
risperidone - adverse effects (2239) 2239
schizophrenia - drug therapy (2239) 2239
index medicus (2013) 2013
pharmacology & pharmacy (1943) 1943
risperidone - therapeutic use (1927) 1927
olanzapine (1673) 1673
middle aged (1587) 1587
treatment outcome (1282) 1282
adolescent (1144) 1144
double-blind (1102) 1102
antipsychotic agents - administration & dosage (1072) 1072
haloperidol (1048) 1048
aged (966) 966
clozapine (937) 937
clinical neurology (878) 878
neurosciences (852) 852
drug therapy (803) 803
atypical antipsychotics (793) 793
antipsychotic drugs (765) 765
antipsychotics (749) 749
psychotic disorders - drug therapy (722) 722
psychiatric status rating scales (720) 720
risperidone - administration & dosage (718) 718
benzodiazepines - adverse effects (651) 651
dose-response relationship, drug (626) 626
double-blind method (626) 626
child (623) 623
psychotropic drugs (618) 618
schizophrenic psychology (616) 616
benzodiazepines - therapeutic use (614) 614
efficacy (600) 600
aripiprazole (569) 569
quetiapine (565) 565
drugs (551) 551
risk factors (549) 549
drug therapy, combination (540) 540
quetiapine fumarate (516) 516
children (479) 479
young adult (460) 460
research (440) 440
psychology, clinical (436) 436
clozapine - adverse effects (422) 422
care and treatment (416) 416
pediatrics (415) 415
dosage and administration (414) 414
neuroleptics (408) 408
placebo (381) 381
psychosis (381) 381
dibenzothiazepines - therapeutic use (380) 380
safety (378) 378
drug administration schedule (377) 377
dibenzothiazepines - adverse effects (369) 369
mental disorders (369) 369
adolescents (367) 367
clozapine - therapeutic use (362) 362
complications and side effects (362) 362
bipolar disorder - drug therapy (356) 356
risk (351) 351
schizophrenia - diagnosis (349) 349
retrospective studies (343) 343
antipsychotic agents - pharmacology (340) 340
bipolar disorder (334) 334
weight gain - drug effects (331) 331
schizoaffective disorder (325) 325
prospective studies (322) 322
follow-up studies (321) 321
haloperidol - adverse effects (321) 321
piperazines - therapeutic use (316) 316
time factors (316) 316
analysis (312) 312
aged, 80 and over (307) 307
benzodiazepines (304) 304
clinical trials (301) 301
medicine, general & internal (295) 295
piperazines - adverse effects (294) 294
severity of illness index (292) 292
basal ganglia diseases - chemically induced (285) 285
health aspects (283) 283
randomized controlled trials as topic (283) 283
pirenzepine - analogs & derivatives (276) 276
haloperidol - therapeutic use (274) 274
prevalence (270) 270
medicine & public health (261) 261
trial (260) 260
antipsychotic (259) 259
symptoms (255) 255
rating-scale (252) 252
side effects (247) 247
open-label (244) 244
dementia (241) 241
animals (236) 236
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5854) 5854
French (69) 69
German (62) 62
Spanish (56) 56
Dutch (16) 16
Hungarian (10) 10
Japanese (10) 10
Russian (10) 10
Polish (9) 9
Turkish (9) 9
Portuguese (7) 7
Italian (6) 6
Danish (5) 5
Chinese (4) 4
Norwegian (3) 3
Swedish (3) 3
Czech (2) 2
Hebrew (2) 2
Arabic (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2006, Volume 45, Issue 7, pp. 771 - 791
Despite increasing use of psychotropic medications in children and adolescents, data regarding their efficacy and safety are limited. Endocrine and metabolic... 
antipsychotics | children and adolescents | side effects | mood stabilizers | metabolic | endocrine | Mood stabilizers | Antipsychotics | Endocrine | Side effects | Children and adolescents | Metabolic | POLYCYSTIC-OVARY-SYNDROME | PSYCHIATRY | RISPERIDONE-INDUCED HYPERPROLACTINEMIA | DEFICIT HYPERACTIVITY DISORDER | PSYCHOLOGY, DEVELOPMENTAL | ATYPICAL ANTIPSYCHOTIC AGENTS | DIETARY GLYCEMIC INDEX | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | 3RD NATIONAL-HEALTH | PEDIATRICS | INDUCED WEIGHT-GAIN | CORONARY-HEART-DISEASE | CARDIOVASCULAR RISK-FACTORS | Outcomes of Treatment | Stimulants | Body Weight | Drug Therapy | Body Height | Risk | Safety | Children | Adolescents | Metabolism | Symptoms (Individual Disorders) | Life Style | Polycystic Ovary Syndrome - etiology | Antipsychotic Agents - adverse effects | Humans | Endocrine System Diseases - etiology | Male | Dibenzothiazepines - adverse effects | Female | Weight Gain - drug effects | Valproic Acid - adverse effects | Child | Drug Administration Schedule | Psychotic Disorders - psychology | Quetiapine Fumarate | Serotonin Uptake Inhibitors - adverse effects | Lithium Compounds - adverse effects | Dibenzothiazepines - administration & dosage | Antipsychotic Agents - administration & dosage | Valproic Acid - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Metabolic Diseases - etiology | Adolescent | Psychotic Disorders - drug therapy | Hyperprolactinemia - etiology | Lithium Compounds - administration & dosage | Psychotropic drugs | Complications and side effects | Care and treatment | Research | Attention-deficit hyperactivity disorder
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 08/2018, Volume 38, Issue 4, pp. 317 - 326
Journal Article
Journal Article
Journal Article
Brain Research, ISSN 0006-8993, 2014, Volume 1583, Issue 1, pp. 255 - 268
Journal Article
JOURNAL OF PSYCHIATRY & NEUROSCIENCE, ISSN 1180-4882, 07/2019, Volume 44, Issue 4, pp. 287 - 288
Journal Article
Schizophrenia Research, ISSN 0920-9964, 12/2018, Volume 202, pp. 212 - 216
This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion... 
Psychosis | Antipsychotic | COMT | PCET | DEPRESSION | PSYCHIATRY | RISPERIDONE | PREFRONTAL CORTEX | LESIONS | PHENCYCLIDINE | CATECHOL-O-METHYLTRANSFERASE | DYSFUNCTION | OLANZAPINE | DEFICITS | WORKING-MEMORY | Complications and side effects | Medical colleges | Neurosciences | Catechin | Antipsychotic drugs | Analysis | Transferases | Genetic aspects | Psychophysiology
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2015, Volume 54, Issue 9, pp. 718 - 727.e3
Objective Second-generation antipsychotic (SGA) effects in youth were monitored to quantify extrapyramidal side effects (EPS) and to identify risk profiles for... 
Pediatrics | Psychiatry | extrapyramidal | second-generation antipsychotic | parkinsonism | dyskinesia | youth | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | ONSET SCHIZOPHRENIA | SCHIZOAFFECTIVE DISORDER | BIPOLAR I DISORDER | OPEN-LABEL | SIMPSON-ANGUS SCALE | ATYPICAL ANTIPSYCHOTICS | ADOLESCENT SCHIZOPHRENIA | LONG-TERM SAFETY | DOUBLE-BLIND | PEDIATRICS | PLACEBO-CONTROLLED TRIAL | Multivariate Analysis | Prospective Studies | Akathisia, Drug-Induced - epidemiology | Antipsychotic Agents - adverse effects | Humans | Male | Thiazoles - therapeutic use | Thiazoles - adverse effects | Aripiprazole - adverse effects | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Mental Disorders - classification | Aripiprazole - therapeutic use | Risperidone - adverse effects | Female | Parkinson Disease, Secondary - chemically induced | Drug Therapy, Combination | Child | New York | Parkinson Disease, Secondary - epidemiology | Quetiapine Fumarate - adverse effects | Dyskinesia, Drug-Induced - epidemiology | Piperazines - therapeutic use | Piperazines - adverse effects | Quetiapine Fumarate - therapeutic use | Regression Analysis | Mental Disorders - drug therapy | Adolescent | Benzodiazepines - adverse effects | Benzodiazepines - therapeutic use | Medical treatment | Risk factors | Parkinsons disease | Child & adolescent psychiatry
Journal Article
Expert Opinion on Drug Safety, ISSN 1474-0338, 08/2014, Volume 13, Issue 8, pp. 1031 - 1042